Artificial intelligence advances breast cancer risk prediction and detection

Artificial intelligence is being integrated into mammography to improve breast cancer screening and risk prediction. New deep learning models can analyze a single mammogram to estimate a patient's statistical risk of developing cancer over the next five years. Unlike traditional methods, this technology uses volumetric breast density and parenchymal texture analysis—patterns invisible to the human eye—to provide a numerical probability of disease onset.

In clinical settings, such as the DMI medical center, software like Transpara is being utilized to assist specialists. This tool identifies suspicious findings and assists in the detection of potential lesions, acting as a support for radiologists rather than a replacement. These advancements aim to move healthcare toward personalized screening models, tailoring preventative measures to an individual's specific risk profile rather than applying uniform guidelines to the entire population.